Abbott Laboratories Acquires Facet Biotech for $450,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1fc5e57d-5d44-46c3-8a33-1de1651eefd3&Preview=1 - Date
3/10/2010 - Company Name
Facet Biotech - Mailing Address
1500 Seaport Blvd Redwood City, CA 94063 - Company Description
With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company. Combining our expertise in antibody engineering with a disciplined, biology-driven research approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives. - Website
http://www.facetbiotech.com - Transaction Type
M&A - Transaction Amount
$450,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Abbott Laboratories is acquiring Facet biotech in a deal worth $450M. According to Abbott, it will pay $27 per share in cash for Facet, for a purchase price of approximately $722M less Facet’s cash and marketable securities worth $272M.
